We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Matthew Mossanen

Matthew Mossanen MD

Assistant Professor of Surgery, Harvard Medical School, Brigham and Women's Hospital, Division of Urology, Boston, Massachusetts

Recent Contributions to PracticeUpdate:

  1. Upper Tract Urothelial Cell Carcinoma: Part 2
  2. Genitourinary Tumor Board: Bladder Cancer
  3. Renal Masses in a Functionally Solitary Kidney: Adjuvant Therapy
  4. Health-Related QoL of Patients With Bladder Cancer Undergoing Robot vs Open Radical Cystectomy
  5. Outcomes and Recurrence Patterns of Sarcomatoid Urothelial Carcinoma
  6. Practical Issues With Use of Edrafitinib in Urothelial Carcinoma
  7. Analysis of Recurrence After Neoadjuvant Bladder Cancer Treatment: Practical Implications
  8. ASCO: Outcomes of Patients With Metastatic Urothelial Carcinoma Following Discontinuation of Enfortumab-Vedotin
  9. ASCO: Adjuvant Chemotherapy Plus Novel Therapies for Muscle-Invasive Bladder Cancer
  10. Pattern of Adverse Events With New Immuno-Oncology Agents: Implications for Monitoring

Most Read This Week

Recently Updated